CWM
LGND icon

CIBC World Markets’s Ligand Pharmaceuticals LGND Stock Holding History

CIBC World Markets’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$243K Buy
+1,283
New +$247K ﹤0.01% 1039
2025
Q2 		$267K Sell
2,351
-1,623
-41% -$173K ﹤0.01% 1149
2025
Q1 		$418K Buy
+3,974
New +$449K ﹤0.01% 1093
2021
Q2 		– Sell
-2,860
Closed -$272K – 800
2021
Q1 		$272K Buy
+2,860
New +$270K ﹤0.01% 963

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

CIBC World Markets's LGND Position: Q4 2025 in Review

CIBC World Markets opened a new position in Ligand Pharmaceuticals (LGND) in Q4 2025: 1,283 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #1039 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in LGND as recently as Q2 2025.

CIBC World Markets first reported a position in LGND in Q1 2021 and has held it in 4 quarters since. The position peaked at $418K in Q1 2025. 349 funds tracked by Wall St. Rank hold LGND as of Q4 2025.

  • CIBC World Markets held 1,283 shares of Ligand Pharmaceuticals worth $243K as of Q4 2025.
  • Ligand Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Ligand Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1039 holding.
  • CIBC World Markets first reported a position in Ligand Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • CIBC World Markets's Ligand Pharmaceuticals position peaked at $418K in Q1 2025.
  • 349 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.